Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Mass drug administration for the elimination of lymphatic filariasis--Port-au-Prince, Haiti, 2011-2012.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 Jun 14;62(23):466-8.

2.

Sustained reduction in prevalence of lymphatic filariasis infection in spite of missed rounds of mass drug administration in an area under mosquito nets for malaria control.

Njenga SM, Mwandawiro CS, Wamae CN, Mukoko DA, Omar AA, Shimada M, Bockarie MJ, Molyneux DH.

Parasit Vectors. 2011 May 25;4:90. doi: 10.1186/1756-3305-4-90.

3.

Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria.

Richards FO, Eigege A, Miri ES, Kal A, Umaru J, Pam D, Rakers LJ, Sambo Y, Danboyi J, Ibrahim B, Adelamo SE, Ogah G, Goshit D, Oyenekan OK, Mathieu E, Withers PC, Saka YA, Jiya J, Hopkins DR.

PLoS Negl Trop Dis. 2011 Oct;5(10):e1346. doi: 10.1371/journal.pntd.0001346. Epub 2011 Oct 11.

4.

Participation in three consecutive mass drug administrations in Leogane, Haiti.

Mathieu E, Direny AN, de Rochars MB, Streit TG, Addiss DG, Lammie PJ.

Trop Med Int Health. 2006 Jun;11(6):862-8.

5.

A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti.

Boyd A, Won KY, McClintock SK, Donovan CV, Laney SJ, Williams SA, Pilotte N, Streit TG, Beau de Rochars MV, Lammie PJ.

PLoS Negl Trop Dis. 2010 Mar 23;4(3):e640. doi: 10.1371/journal.pntd.0000640.

7.

Progress toward elimination of lymphatic filariasis--Togo, 2000--2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Jul 29;60(29):989-91.

8.
10.

Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine.

Ramaiah KD, Vanamail P, Das PK.

Trans R Soc Trop Med Hyg. 2007 Mar;101(3):250-5. Epub 2006 Aug 4.

PMID:
16890256
11.

The role of personal opinions and experiences in compliance with mass drug administration for lymphatic filariasis elimination in Kenya.

Njomo DW, Amuyunzu-Nyamongo M, Magambo JK, Njenga SM.

PLoS One. 2012;7(11):e48395. doi: 10.1371/journal.pone.0048395. Epub 2012 Nov 19.

12.

The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt.

El-Setouhy M, Abd Elaziz KM, Helmy H, Farid HA, Kamal HA, Ramzy RM, Shannon WD, Weil GJ.

Am J Trop Med Hyg. 2007 Dec;77(6):1069-73.

13.

Knowledge and practice related to compliance with mass drug administration during the Egyptian national filariasis elimination program.

Abd Elaziz KM, El-Setouhy M, Bradley MH, Ramzy RM, Weil GJ.

Am J Trop Med Hyg. 2013 Aug;89(2):260-4. doi: 10.4269/ajtmh.12-0491. Epub 2013 Jun 10.

14.

Impact of mass drug administration on elimination of lymphatic filariasis in Surat city, India.

Vaishnav KG, Desai HS, Srivastava PK, Joshi PT, Kurian G, Thakor HG, Dhariwal AC.

J Commun Dis. 2012 Dec;44(4):251-9.

PMID:
25145075
15.

Comparison of methods for estimating drug coverage for filariasis elimination, Leogane Commune, Haiti.

Mathieu E, Deming M, Lammie PJ, McLaughlin SI, Beach MJ, Deodat DJ, Addiss DG.

Trans R Soc Trop Med Hyg. 2003 Sep-Oct;97(5):501-5.

PMID:
15307410
16.

Endpoints for lymphatic filariasis programs.

Grady CA, de Rochars MB, Direny AN, Orelus JN, Wendt J, Radday J, Mathieu E, Roberts JM, Streit TG, Addiss DG, Lammie PJ.

Emerg Infect Dis. 2007 Apr;13(4):608-10.

17.

Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs.

Cantey PT, Rout J, Rao G, Williamson J, Fox LM.

PLoS Negl Trop Dis. 2010 Jun 29;4(6):e728. doi: 10.1371/journal.pntd.0000728.

18.

Awareness and coverage of mass drug administration for elimination of lymphatic filariasis: a community based cross sectional study in Nepal.

Adhikari RK, Sherchand JB, Mishra SR, Ranabhat K, Wagle RR.

J Community Health. 2015 Feb;40(1):34-40. doi: 10.1007/s10900-014-9891-1.

PMID:
24996654
19.

Lymphatic filariasis elimination programme in Andaman and Nicobar Islands, India: drug coverage and compliance post eight rounds of MDA.

Sunish IP, Shriram AN, Sivan A, Kartick C, Saha BP, Vijayachari P.

Trop Doct. 2013 Jan;43(1):30-2. doi: 10.1177/0049475513482123.

PMID:
23550201
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk